Intestinal Disease Education and Awareness Society IDEAS -
Lipid Therapeutics Successfully Files a US IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis HEIDELBERG, Germany, April 10, 2013 /PRNewswire/ — IND paves the way for the US element of a global Phase III development program with LT-02 in conjunction with European licensee Dr. Falk Pharma GmbH, whose pivotal study will start […]
The post Lipid Therapeutics Successful Therapy for Ulcerative Colitis appeared first on Intestinal Disease Education and Awareness Society IDEAS.